Literature DB >> 11115561

Follicular thyroid cancer cells: a model of metastatic tumor in vitro (review).

T Hoelting1, P E Goretzki, Q Y Duh.   

Abstract

We used a thyroid metastatic tumor model to analyze some of the mechanisms of invasion and metastasis in culture. Chronic TSH stimulation (thyroid stimulating hormone) was associated with enhanced tumor proliferation and aggressiveness. We present a unique metastatic tumor model including three follicular thyroid cancer cell lines using a human primary tumor and two metastases of the same patient. They contain thyroglobulin, have intact thyroid functions and response to TSH. Investigating growth factor sensitivity we found that the amplitude of stimulation or inhibition of invasion was significantly smaller in both metastatic cell lines. Unstimulated cells of the lung metastasis had the highest basal invasive potential, but were only minimally affected by the stimulation of growth factors. In contrast, the parental cell line had the lowest basal invasiveness, but was considerably stimulated by growth factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11115561

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Limited adequacy of thyroid cancer patient follow-up at a Canadian tertiary care centre.

Authors:  Elaine Lam; Scott S Strugnell; Chris Bajdik; Daniel Holmes; Sam M Wiseman
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

2.  An in vivo mouse model of metastatic human thyroid cancer.

Authors:  Lisa Zhang; Kelli Gaskins; Zhiya Yu; Yin Xiong; Maria J Merino; Electron Kebebew
Journal:  Thyroid       Date:  2014-03-10       Impact factor: 6.568

3.  Different cDNA microarray patterns of gene expression reflecting changes during metastatic progression in adenoid cystic carcinoma.

Authors:  Dan Huang; Wantao Chen; Ronggen He; Fan Yu; Zhiyuan Zhang; Weiliu Qiu
Journal:  World J Surg Oncol       Date:  2003-12-19       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.